Immuron Ltd — Capital/Financing Update 2008

Apr 21, 2008

==> picture [85 x 107] intentionally omitted <==

22 April 2008

Company Announcements Office Australian Securities Exchange Sydney NSW

Shareholder Share Purchase Plan

The Directors of Anadis Limited (“Company”) are pleased to announce that the Company is making an offer to eligible shareholders to participate in the Company’s Shareholder Share Purchase Plan (“Plan”).

Under the Plan, Eligible Members who hold Anadis Limited shares at 5.00pm, Melbourne time on Thursday 24 April 2008 , will be able to purchase up to $5,000 worth of new shares, irrespective of the number of shares they currently hold.

The issue price for shares offered under the Plan will be 5 cents per share, which represents an 18% discount to the volume weighted average market price of the Company’s shares for the five trading days immediately preceding the date of this announcement.

The Plan allows Anadis shareholders to acquire the shares without brokerage or costs which would otherwise apply to a purchase of shares on the Australian Stock Exchange.

The Directors have determined that a maximum of 15,000,000 shares will be issued under the Plan. Accordingly, if the aggregate number of shares applied for exceed 15,000,000 shares; the Directors will reject applications lodged after that number has been obtained.

Intention of Directors

Each Director holding shares in the Company intends to take up their full $5,000 entitlement to Shares under the Offer.

Purpose of the Offer

The Offer is being made to Eligible Members to provide then with the opportunity to acquire shares at a time when the Company is refocusing its direction to the commercialisation of colostrum derived high value health products, such as antibodies and other bioactives used in the treatment or prevention of infectious and autoimmune diseases. The funds raised will assist in the ongoing research which we are currently conducting with a number of leading medical centres based at leading Australian and overseas universities and research centres.

1

Participation

Participation in this Offer is optional. There is no obligation on you to accept the Offer.

The Offer under the Plan is non-renounceable. This means you cannot transfer your right to subscribe for shares under the Offer to anyone else.

You are an Eligible Member and entitled to participate in the Plan only if you are a registered holder of shares in the Company with a registered address in either Australia or New Zealand.

Closing Date

The closing date for acceptance of the offer is Monday 26 May 2008.

A copy of the invitation to participate in the offer, together with the terms and conditions of the Share Purchase Plan and a personalised Plan application form, will be posted to Eligible shareholders in the week commencing 5 May.

I look forward to your participation in the offer to shareholders.

Yours faithfully

==> picture [139 x 43] intentionally omitted <==

Roman Zwolenski Chairman

__________________________________________________________________________ ANADIS LIMITED ABN 80 063 114 045

4 Capital Link Drive Campbellfield Victoria Australia 3061 Ph (61) 3 9358 6388 Fax (61) 3 9358 6399 email: info@anadis.com.au website: www.anadis.com.au

2